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  Objective(s): Non-syndromic sensorineural hearing loss (NSHL) is a common disorder affecting 
approximately 1 in 500 newborns. This type of hearing loss is extremely heterogeneous and 
includes over 100 loci. Mutations in the GJB2 gene have been implicated in about half of autosomal 
recessive non-syndromic hearing loss (ARNSHL) cases, making this the most common cause of 
ARNSHL. For the latter form of deafness, most frequent genes proposed include GJB2, SLC26A4, 
MYO15A, OTOF, and CDH23 worldwide. 
Materials and Methods: The aim of the present study was to define the role and frequency of 
MYO15A gene mutation in Iranian families. In this study 30 Iranian families were enrolled with 
over three deaf children and negative for GJB2. Then linkage analysis was performed by six DFNB3 
short tandem repeat markers. Following that, mutation detection accomplished using DNA 
sequencing. 
Results: One family (3.33%) showed linkage to DFNB3 and a novel mutation was identified in the 
MYO15A gene (c.6442T>A) as the disease-causing mutation. Mutation co-segregated with hearing 
loss in the family but was not present in the 100 ethnicity-matched controls. 
Conclusion: Our results confirmed that the hearing loss of the linked Iranian family was caused by 
a novel missense mutation in the MYO15A gene. This mutation is the first to be reported in the 
world and affects the first MyTH4 domain of the protein. 
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Introduction 
Hearing loss (HL) is the most common sensory 
disorder estimated to affect 70 million people 
worldwide. This disorder is mostly a birth defect that 
affects 1 in 500 newborns (1). HL is extremely 
heterogeneous and can result from genetic or 
environmental factors or both (2). More than 50% of 
hearing loss cases are caused by genetic factors, of 
which 70% are non-syndromic (NSHL) and the 
remaining 30% are attributed to syndromic forms 
(3). Different loci have been identified for NSHL and 
have been named according to their mode of 
inheritance (DFNB for autosomal recessive, DFNA for 
autosomal dominant, and DFN for X-linked) and the 
time of their identification (ex. DFNB1-DFNB95) (4).  
Over 60 genes have been discovered causing NSHL 
(Hereditary hearing loss homepage) (5).Studies have 
indicated that GJB2 gene mutations are a major cause 
of ARNSHL. The contribution of other loci to the 
ARNSHL is much lower. The extreme heterogeneity 
of HL makes it cumbersome to identify the genetic 
cause of this disease in single families leading to 
difficulties in their genetic counseling and testing. 
Despite previous intensive GLA and candi-date gene 
screening, a large proportion of ARNSHL remains 
genetically unexplained (5, 6). Due to the high 
heterogeneity of HL, researchers have suggested 
studying of large families in populations like middle 
east in which consanguineous marriage rate is high 
(7). Iran, with specific population characteristics
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 such as high consanguineousmarri-age rate and 
heterogeneous population, offers a good opportunity 
to study rare autosomal recessive disorders 
including ARNSHL. Studies in Iran showed that 
contribution proportion of GJB2 mutations in HL in 
different populations varies ranging from 
approximately 27%–38% in the north to 0%–0.4% in 
the southeast(8-10). So far, the contribution of 
mutations in other genes associated with HL has 
been identified only in a limited number of Iranian 
families and it seems in order to determine a more 
exact contribution of each one of these genes in 
Iranian families, more extensive studies are required 
to be done. For ARNSHL, the most frequent causative 
genes in order of frequency are GJB2, SLC26A4, 
MYO15A, OTOF, and CDH23. Mutations in the 
SLC26A4 gene, which is located at the DFNB4 locus 
are the second most frequent cause of ARNSHL and 
in order of frequency after GJB2 and SLC26A4, 
mutations in MYO15A is the third most frequent 
cause of ARNSHL in the world (11). Forty-three 
mutations have been reported in MYO15A, most of 
which have been found using GLA in consanguineous 
families from specific countries (12-15). 
MYO15A encodes an unconventional myosin XVa, 
which has a role in stereocilia formation (16). 
Myosins are molecular motor proteins that drive the 
moment of actin filaments via ATP hydrolysis to 
facilitate muscle contraction, organelle trafficking, 
cell movement, cytokinesis, and signal transduction 
(17). The protein is unique among unconventional 
myosins in that it includes a long N-terminal domain 
(coded by exon 2) that is alternatively spliced to 
generate distinct class 1 and class 2 protein isoforms. 
The N-terminal domain is required for normal 
hearing, as premature stop mutations that result in 
loss of this domain cause DFNB3 hearing loss (18, 
19). Myosin XVa also contains domains that are 
conserved within the myosin protein family, 
including the motor domain, IQ motifs(calmodulin/-
myosin light chain binding), MyTh4 domains 
(myosin tail like homology region 4), FERM motifs 
(4.1 protein, Ezrin, Radixin, and Moesin), SH3 domain 
(Src homology 3), and the PDZ ligand domain. Many 
missense and nonsense mutations in coding exons of 
the motor domain, FERM, and MyTh4 domain have 
been identified which cause profound HL in different 
populations (20-22) . 
In this study, we have characterized an ARNSHL 
family from the west of Iran and identified a novel 
mutation in the MYO15A gene. This novel mutation 
has been identified in the highly conserved MyTh4 
domain in this family. 
 
Materials and Methods 
Sampling and genomic DNA extraction 
In this descriptive laboratory study, 30 Iranian 
families with at least 2 affected children were 
selected, informational questionnaires were filled 
out by family members, and clinical assessments 
were performed, also consent was obtained from all 
family members. This research has been approved by 
the National Institute of Genetic Engineering and 
Biotechnology and Cellular and Molecular Research 
Center, Shahrekord University of Medical Sciences, 
Shahrekord, Iran. All cases of syndromic hearing loss 
caused by environmental factors such as ototoxic 
medications, hepatitis, head trauma, or meningitis 
were excluded. All families were informed and 
written consent was taken and 5 ml peripheral 
blood, in tubes containing 0.5 M EDTA from all 
available members of all families was obtained. 
Genomic DNA was extracted from blood samples 
using the phenol-chloroform standard method. DNA 
quality (purity and DNA concentration) was checked 
by spectroscopy (UNICO 2100, USA) (23, 24).  
 
GJB2 mutation screening  
At least one affected member from every 
pedigree was selected for detection of GJB2 
mutations and reaction was carried out in 
accordance with previous protocols (25). PCR 
product was run in an 8% polyacrylamide gel 
electrophoresis (PAGE) at 45 mA for 1.5 hr. DNA 
bands were visualized by silver staining. A single 
PCR product of 809 bp was obtained and DNA 
sequencing of the PCR product was carried out in 
order to detect any change in the gene. 
 
S-LINK analysis, DFNB3 STR marker, and linkage 
analysis 
For S-Link and LOD score calculation, we used the 
Easy linkage plus (ver. 5.05) genetic software (26). 
For S-LINK calculation we used FastSlink version 
2.51. Two-point and multipoint parametric LOD 
scores were calculated using Superlink (ver. 1.6) and 
GeneHunter (ver. 2.91), respectively. For LOD score 
calculations using these software packages, 
inheritance pattern of autosomal recessive, complete 
penetrance, and disease allele frequency of 0.001 
were assumed. Haplopainter version 029.5 software 
package was used for reconstruction of haplotypes 
(27). Negative subjects for GJB2 mutations were 
selected for linkage analysis. For GLA, 6 different STR 
markers were used. Upon encountering an 
uninformative marker, further markers were 
examined. Table 1 summarizes the markers used in 
the study and their general characteristics. The 
criteria for selecting these markers are as following: 
greater heterogeneity values, shorter fragments in 
amplicon length and lying close to the known locus. 
STR markers were selected based on their physical 
distance found at NCBI UniSTS, and Touchdown 
program was used for markers. Thermal cycling 
conditions for amplifying markers were in 
accordance with previous protocols (25).  
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Table 1. Genetic STR markers used in this study and their characteristics 
 
Heterozygosity 
  
Size (bp) Reverse primer Forward primer STR 
0.72 169-185  GGCCACCATAATCATGTCAGACAAT 
 
GGCCACCATAATCATGTCAGACAAT D17S921 
0.70 159-203 GAGAATCACCTGAACCCG AATTCAAAGGCTAAAAGCAAAC D17S1843 
0.76 119-131 AAGGGCTTGCTTTGAC  ACTATCCGCCCAATACA 
 
D17S953 
0.62 177-187  TGCCTAAACTGCTTTCAGGTGAG 
 
 TGCACAGGCCAATTCCTTAC 
 
D17S1857 
0.71 103-151 TACATTTAATGCAGGATGCC CTCTTTGTGCTTGGCAGGGT D17S740 
0.81 139-163  ATATTTCAATATTGTAACCAGTCCC 
 
CCAACATCTAGAATTAATCAGAATC D17S2196 
 
Mutation screening for the MYO15A gene  
Sixty-six exons of the MYO15A gene [NM_016239.3] 
and flanking regions were amplified using designed 
primers by the Oligo (ver. 7.05) software. Reaction 
conditions for amplifying exons in 50 μl was as follows: 
2 μl MgCl2 (50 mM), 2.5 μl  PCR buffer (10X), 0.5 μl of 
each of forward and reverse  primers (50 PM), 0.5 U 
Taq DNA polymerase (5U/ul), 1 μl  dNTP mix (10 mM) 
and 1 μl genomic DNA     (about 100 ng). PCR was done 
as follows: 95 °C for primary denaturation for 5 min; 35 
cycles of 94 °C denaturation for 1 min, 59 °C annealing 
temperature for 1 min, 72 °C extension for 1 min, and a 
final extension at 72 °C for 5 min. In order to detect any 
variant in the gene sequence, direct sequencing of 
amplified exons was performed bi-directionally using 
ABI 3730XL. 
 
Pathogenicity investigation of novel variant 
Co-segregation study in family members was 
accomplished and investigation of conservative 
amino acid coding of novel variant confirmed the 
presence of mutation. The absence of new variation 
in 100 healthy control samples also confirmed the 
mutation performed by restriction fragment length 
polymorphism (RFLP) using Msc1 restriction 
enzyme. In the current study, we used the following 
primers: F-5’ATTTATATGGGCAGGGGCAC3’ and R-5’
AGGCGGCCAGCAGTGGCC 3’ for the amplification.  
 
Results 
Most of the subjects in this study exhibited severe 
to profound bilateral sensorineural hearing loss.  
70% of families in this study were consanguineous 
families. According to the information in the 
pedigree, the type of hearing loss was autosomal 
recessive non-syndromic. 
Mutation 35delG was identified in 5 families out 
of 30 families by sequencing of the coding region of 
the GJB2 gene. These families were homozygous for 
this mutation and were eliminated from further 
analysis. The remaining families were further 
analyzed for the linkage to DFNB1 using 3 
informative markers. However, linkage analysis 
could not find any other family linked to the DFNB1 
locus. For linkage analysis to other loci, first S-LINK 
values were calculated for the remaining families. 
14families had S-LINK values ≥3, 5 families were of 
S-LINK values <2, and the rest of families had S-LINK 
values 2 to 3. GLA for the DFNB3 locus was carried 
out by 6 STR markers. By haplotype analysis, out of 
the 25 remaining families, one family was found to 
be linked to this locus and this linked family 
displayed complete pattern of linkage (Figure 1). 
 
 
 
 
 
Figure1. Pedigree and haplotypes of the family linked to DFNB3. The order of markers is based on the Marshfield map
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Figure 2. Audiograms for a proband member (18 in Figure 1) of a family linked to DFNB3. “O” indicates air conduction for the right ear, 
while “X” indicates air conduction for the left ear. Audiograms of the affected individual had shown severe to profound hearing loss at two 
different time intervals 
 
Audiogram analysis of this family confirmed HL to be 
profound in all affected subjects of the family (Figure 
2). Calculated multipoint LOD score for this family 
was 3.15, which confirmed the linkage to the locus. 
DNA sequencing of 66 coding exons of the MYO15A 
gene demonstrated a new variant in the homozygous 
state in exon 30. We first analyzed all 
polymorphisms of the gene from all data banks. This 
novel variant was a missense substitution and 
caused the substitution of nucleotide T to A in the 
location 6442 of the coding region of MYO15A 
(c.6442T>A)andsubstitutionoftryptophanfor 
arginine at residue 2148 (p.Trp2148Arg). The 
ConSurf web server calculated the conservative 
score for the residue to be 8, which implies it as 
highly conserved among diverse species (Figure 3). 
Co-segregation showed that variant in affected 
subjects and in parents was in homozygous and 
heterozygous states, respectively. One normal 
individual was homozygous for the normal 
allele(Figure 4). We analyzed the variant in 100 
normal controls and no case was found to be positive 
for it. Thus, the observations would confirm the 
pathogenicity of the novel variant. 
 
 
Figure 3.conservity of altered amino acids in different species. Calculated score for amino acid was 8
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Figure 4. Chromatogram results of novel MYO15A variants in an Iranian family 
A: normal alleles. B: A normal subject with hetrozygousc.6442T>A allele. C: A patient with homozygous c.6442T>A allele 
 
Discussion 
In the present study, we analyzed 30 families with 
ARNSHL and found one family (~3%) to be linked to 
DFNB3 by genetic linkage analysis (GLA). After DNA 
sequencing of the MYO15A gene, a novel variant 
(c.6442T>A, p.Trp2148Arg) was identified in the 
first MyTH4 domain. MYO15A with 66 coding exons 
encodes an unconventional myosin (myosin XV) that 
is expressed in the cochlea (19). This protein has 
important roles in the differentiation and elongation 
of the inner ear hair cell stereocilia , and it is also 
necessary for actin organization in hair cells (28). 
Mutations that cause hearing loss were first 
identified at the DFNB3 locus, in residents of a village 
in Indonesia. It was estimated that mutation 
frequencies were 9% among the inbred population. 
Since then, many mutations have been reported from 
different countries such as Pakistan, India, Turkey, 
Indonesia, and Brazil, interestingly, all of which 
belong to non-Caucasian populations (13, 14). 
Recently two compound heterozygote variants have 
been reported in Korean and Chinese families (15, 
29). In addition,a novel homozygous mutation 
(c.9316dupC) in second MyTh4 of the MYO15A gene 
was identified by exome sequencing and Sanger 
sequencing in a Chinese family with ARNSHL (30). 
The novel mutation, found in this study, is located in 
the first domain of myosin tail homology4 (MTH4). 
To date, 7 mutations have been identified in this 
domain that are missense mutations. The MyTH4 
domain of myosin has some roles in microtubule 
binding, as well as in actin binding at the plasma 
membrane (15, 31). Some studies suggest that 
MyTH4/FERM domain in MYOXVA is essential for its 
localization to stereocilia tips, although, their specific 
function is not been clearly known (18, 32, 33). 
MyTh4 domain contains a high percentage of 
conserved amino acids relative to other domains of 
the protein(33). Therefore, mutations in this domain 
can have a significant effect on proper function and 
structure of the protein. The c.6442T>A mutation 
leads to substitution of tryptophan for arginine 
amino acid at codon 2148. Tryptophan is a highly 
hydrophobic amino acid with aromatic structure, 
while arginine is a hydrophilic and positive charged 
amino acid. This amino acid substitution interferes 
with protein/microtubules interaction and actin and 
consequently disrupts the normal auditory function. 
MyTH4 domain interacts with PDZ domain of whirlin 
protein which is a cytoskeletal scaffold protein and is 
essential for normal auditory function. The co-
localization of MYOXVA and whirlin proteins is 
essential for the assembly of actin microfilaments at 
stereocilia tips. In addition to the change in protein 
structure, this mutation interferes with the 
interaction between these two proteins and prevents 
the formation of actin microfilaments that is 
required for normal hearing. Different studies on 
Iranian populations show that mutations in GJB2 and 
SLC26A4 are the first and second hearing loss 
causing mutations, respectively(34). To date, up to 
10 mutations in the MYO15A gene have been 
identified in the Iranian population. Thus, according 
to the current studies the DFNB3 locus in hearing 
loss might rank third after GJB2 and SLC26A4. 
 
Conclusion 
We have identified a novel mutation in the MYO15A 
gene in an Iranian family. This mutation affects the 
first MyTH4 domain of the protein. This region is 
highly conserved and should be investigated in 
future studies. 
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